LPAR6
| Symbol | LPAR6 |
|---|---|
| HGNC ID | 18610 |
| Alternative symbols | – |
| Entrez Gene | – |
| OMIM | – |
| RefSeq | – |
| UniProt | – |
| Chromosome | 13q14 |
| Locus supplementary data | – |
LPAR6 (Lysophosphatidic acid receptor 6) is a G protein-coupled receptor (GPCR) that is encoded by the LPAR6 gene in humans. This receptor is part of the lysophospholipid receptor family, which is involved in various cellular processes, including cell proliferation, migration, and survival.
Function[edit]
LPAR6 is primarily activated by lysophosphatidic acid (LPA), a bioactive lipid that mediates diverse biological functions. The receptor is known to play a crucial role in the regulation of hair growth and skin homeostasis. Mutations in the LPAR6 gene have been associated with hypotrichosis and other hair growth disorders.
Clinical Significance[edit]
Mutations in the LPAR6 gene can lead to autosomal recessive hypotrichosis, a condition characterized by sparse hair growth on the scalp and body. This condition is part of a group of disorders known as ectodermal dysplasias, which affect the development of the skin, hair, nails, and teeth.
Pathways[edit]
LPAR6 is involved in several signaling pathways, including the RhoA and Ras pathways, which are important for cytoskeletal organization and cell motility. The receptor's activation can lead to the phosphorylation of downstream targets, influencing various cellular responses.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which LPAR6 influences hair growth and its potential role in other physiological and pathological processes. Studies are also exploring the therapeutic potential of targeting LPAR6 in conditions such as alopecia and cancer.
See also[edit]
References[edit]
External links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian